At high concentrations, as they may occur in inflamed tissue, extracellular Hsp are potent activators of macrophages or dendritic cells and this adjuvant-like property is being used for tumor vaccines consisting of recombinant Hsp plus isolated tumor cell peptides [11, 30]. This evidence concerns the gene HSP90B2P and neoplasm.